Smoljo, T., Tomic, B., Lalić, H., Dembitz, V., Batinić, J., Bedalov, A. & Višnjić, D. (2023). Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia. Frontiers in Pharmacology, 14.. doi: 10.3389/fphar.2023.1258151
Smoljo, Tomislav, et al. "Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia." Frontiers in Pharmacology, vol. 14, 2023. https://doi.org/10.3389/fphar.2023.1258151
Smoljo, Tomislav, Barbara Tomic, Hrvoje Lalić, Vilma Dembitz, Josip Batinić, Antonio Bedalov and Dora Višnjić. "Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia." Frontiers in Pharmacology 14 (2023). https://doi.org/10.3389/fphar.2023.1258151
Smoljo, T., et al. (2023) 'Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia', Frontiers in Pharmacology, 14. doi: 10.3389/fphar.2023.1258151
Smoljo T, Tomic B, Lalić H, Dembitz V, Batinić J, Bedalov A, and sur.. Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia. Frontiers in Pharmacology [Internet]. 2023 October 26 [cited 2024 October 06];14. doi: 10.3389/fphar.2023.1258151
T. Smoljo, et al., "Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia", Frontiers in Pharmacology, vol. 14, October 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:853860. [Accessed: 06 October 2024]